Clinical TrialID 7240
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
NCT00352495
Brain and Central Nervous System Tumors|Neurofibromatosis Type 1
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7240
- Evidence Id
- 7240
- Core Evidence Id
- 7240
- Source Clinical Trial Id
- 7230
- Herb2 Clinical Trial Id
- HBCT007230
- Nct Id
- NCT00352495
- Title
- Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Brain and Central Nervous System Tumors|Neurofibromatosis Type 1
- Study Type
- Interventional
- Study Design
- Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
- Intervention
- DRUG: carboplatin|DRUG: vinblastine sulfate
- Intervention Allocation
- Intervention Model
- Single_Group
- Intervention Mask
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 26
- Outcome Measure
- Maximum tolerated dose and recommended phase II dose of vinblastine in combination with carboplatin, length of study|Acute and dose-limiting toxicities, length of study|Other toxicities, length of study
- Sponsor Collaborator
- Children's Oncology Group|National Cancer Institute (NCI)
- Funded By
- NETWORK
- Location
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham, Alabama, 35294, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|Children's National Medical Center, Washington, District of Columbia, 20010-2970, United States|Children's Memorial Hospital - Chicago, Chicago, Illinois, 60614, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202-5289, United States|Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|C.S. Mott Children's Hospital at University of Michigan Medical Center, Ann Arbor, Michigan, 48109-0286, United States|Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, 55455, United States|Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St. Louis, Missouri, 63110, United States|Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York, New York, 10032, United States|SUNY Upstate Medical University Hospital, Syracuse, New York, 13210, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229-3039, United States|Oregon Health and Science University Cancer Institute, Portland, Oregon, 97239-3098, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104-9786, United States|Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, 75390, United States|Baylor University Medical Center - Houston, Houston, Texas, 77030-2399, United States|Children's Hospital and Regional Medical Center - Seattle, Seattle, Washington, 98105, United States|Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|Hopital Sainte Justine, Montreal, Quebec, H3T 1C5, Canada
- Other Id
- ADVL0515|COG-ADVL0515|CDR0000483184
- Start Date
- 2006-06
- Primary Completion Date
- 2011-09
- Completion Date
- 2012-03
- First Posted
- 2006-07-14
- Results First Posted
- Last Update Posted
- 2014-02-13
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00352495
- Title Cn
- Title En
- Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
- Bilingual Status
- semi_complete